Benzinga's Top Upgrades, Downgrades For November 17, 2017

Loading...
Loading...

Top Upgrades

  • Mizuho upgraded Splunk Inc SPLK from Neutral to Buy. Splunk shares gained 15.4 percent to $80.00 in pre-market trading.
  • Analysts at BMO Capital upgraded Anadarko Petroleum Corporation APC from Market Perform to Outperform. Anadarko Petroleum shares fell 0.25 percent to close at $47.50 on Thursday.
  • Macquarie upgraded Comerica Incorporated CMA from Neutral to Outperform. Comerica shares fell 0.58 percent to close at $78.42 on Thursday.
  • Barclays upgraded Moody's Corporation MCO from Equal-Weight to Overweight. Moody's shares rose 0.63 percent to $145.00 in pre-market trading.
  • RBC Capital upgraded L Brands Inc LB from Sector Perform to Outperform. L Brands shares gained 2.69 percent to $50.44 in pre-market trading.
  • Evercore ISI Group upgraded Square Inc SQ from In-Line to Outperform. Square shares rose 1.41 percent to $42.49 in pre-market trading.
  • Analysts at Mizuho upgraded Entergy Corporation ETR from Neutral to Buy. Entergy shares fell 0.61 percent to close at $85.90 on Thursday.
  • Goldman Sachs upgraded Occidental Petroleum Corporation OXY from Neutral to Buy. Occidental Petroleum shares rose 0.86 percent to $67.75 in pre-market trading.


Top Downgrades

  • JP Morgan downgraded Williams-Sonoma, Inc. WSM from Overweight to Underweight. Williams-Sonoma shares fell 11.84 percent to $46.61 in pre-market trading.
  • Deutsche Bank downgraded Buffalo Wild Wings BWLD from Buy to Hold. Buffalo Wild Wings shares declined 2.32 percent to close at $140.90 on Thursday.
  • Gabelli & Co. downgraded Time Inc TIME from Buy to Hold. Time shares climbed 28.06 percent to close at $16.20 on Thursday.
  • Chardan Capital downgraded Ituran Location and Control Ltd. (US) ITRN from Buy to Neutral. Ituran Location shares rose 0.28 percent to close at $36.10 on Thursday.
  • Analysts at Ladenburg Thalmann downgraded Sito Mobile Ltd SITO from Buy to Neutral. SITO Mobile shares gained 6.70 percent to close at $8.12 on Thursday.
  • Deutsche Bank downgraded CarMax, Inc KMX from Buy to Hold. CarMax shares dropped 0.24 percent to close at $70.55 on Thursday.
  • Analysts at Macquarie downgraded Fifth Third Bancorp FITB from Neutral to Underperform. Fifth Third Bancorp shares dropped 0.53 percent to $28.32 in pre-market trading.
  • Credit Suisse downgraded Coca-Cola FEMSA, S.A.B. de C.V. (ADR) KOF from Outperform to Neutral. Coca Cola Femsa shares rose 0.95 percent to close at $67.97 on Thursday.


Top Initiations

  • Argus initiated coverage on Unilever plc (ADR) UL with a Hold rating. Unilever shares closed at $55.76 on Thursday.
  • Goldman Sachs initiated coverage on Boardwalk Pipeline Partners, LP BWP with a Sell rating. The price target for Boardwalk Pipeline Partners set to $14. Boardwalk Pipeline Partners shares closed at $14.60 on Thursday.
  • Analysts at SunTrust Robinson Humphrey initiated coverage on Rev Group Inc REVG with a Buy rating. The price target for Rev Group set to $33. Rev Group shares closed at $24.27 on Thursday.
  • Cowen & Co. initiated coverage on Canada Goose Holdings Inc. GOOS with an Outperform rating. Canada Goose shares closed at $25.06 on Thursday.
  • Analysts at CIBC initiated coverage on Teck Resources Ltd (USA) TECK with an Outperform rating. Teck Resources shares closed at $21.22 on Thursday.
  • Analysts at H.C. Wainwright initiated coverage on Aratana Therapeutics Inc PETX with a Buy rating. The price target for Aratana Therapeutics is set to $10. Aratana Therapeutics shares closed at $6.94 on Thursday.
  • Citigroup initiated coverage Ollie's Bargain Outlet Holdings Inc OLLI with a Sell rating. The price target for Ollie's Bargain is set to $39. Ollie's Bargain shares closed at $44.90 on Thursday.
  • Analysts at KeyBanc initiated coverage on AMN Healthcare Services, Inc. AMN with an Overweight rating. The price target for AMN Healthcare is set to $50. AMN Healthcare shares closed at $43.65 on Thursday.
  • Analysts at Mizuho initiated coverage on Revance Therapeutics Inc RVNC with a Buy rating. The price target for Revance Therapeutics is set to $37. Revance Therapeutics closed at $25.50 on Thursday.
  • DA Davidson initiated coverage of Q2 Holdings Inc QTWO with a Neutral rating. The price target for Q2 Holdings is set to $38. Q2 Holdings shares closed at $44.00 on Thursday.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsDowngradesFinancialsInitiationsSpecialized Financetop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...